EGFR feedback-inhibition by Ran-binding protein 6 is disrupted in cancer
The epidermal growth factor receptor (EGFR) signalling is regulated at multiple levels. Here the authors show that the importin RanBP6 acts as a tumor suppressor in Glioblastoma and regulates EGFR signalling through promoting translocation of STAT3 to the nuclei and repressing EGFR transcription.
Saved in:
Main Authors: | Barbara Oldrini, Wan-Ying Hsieh, Hediye Erdjument-Bromage, Paolo Codega, Maria Stella Carro, Alvaro Curiel-García, Carl Campos, Maryam Pourmaleki, Christian Grommes, Igor Vivanco, Daniel Rohle, Craig M. Bielski, Barry S. Taylor, Travis J. Hollmann, Marc Rosenblum, Paul Tempst, John Blenis, Massimo Squatrito, Ingo K. Mellinghoff |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2017
|
Subjects: | |
Online Access: | https://doaj.org/article/015fa09cb6784ac18a7db7bbdca85e1c |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Age-dependent shift in the de novo proteome accompanies pathogenesis in an Alzheimer’s disease mouse model
by: Megan K. Elder, et al.
Published: (2021) -
Insights into the function of the CRM1 cofactor RanBP3 from the structure of its Ran-binding domain.
by: Karla Langer, et al.
Published: (2011) -
RAn Enlarged Conception of the Subject Matter of Logic
by: John T. Kearns
Published: (2004) -
Ran pathway-independent regulation of mitotic Golgi disassembly by Importin-α
by: Chih-Chia Chang, et al.
Published: (2019) -
The RanBP2/RanGAP1*SUMO1/Ubc9 SUMO E3 ligase is a disassembly machine for Crm1-dependent nuclear export complexes
by: Tobias Ritterhoff, et al.
Published: (2016)